Grey Street Capital’s RxSight RXST Stock Holding History

Grey Street Capital’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$978K	Hold	18,961	–	–	0.13%	176
2023 Q4	$765K	Buy	+18,961	New	+$556K	0.36%	57

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Grey Street Capital's RXST Position: Q1 2024 in Review

Grey Street Capital held its RxSight (RXST) position steady in Q1 2024 at 18,961 shares worth $978K. The position accounts for 0.13% of the portfolio, ranked #176.

Grey Street Capital first reported a position in RXST in Q4 2023 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold RXST as of Q1 2024.

Grey Street Capital held 18,961 shares of RxSight worth $978K as of Q1 2024.
Grey Street Capital left its RxSight share count unchanged in Q1 2024.
RxSight made up 0.13% of Grey Street Capital's portfolio in Q1 2024, its #176 holding.
Grey Street Capital first reported a position in RxSight in Q4 2023 and has held it in 2 quarters since.
197 funds tracked by Wall St. Rank held RxSight as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.